BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23963903)

  • 1. A workflow from untargeted LC-MS profiling to targeted natural product isolation.
    Callahan DL; Elliott CE
    Methods Mol Biol; 2013; 1055():57-70. PubMed ID: 23963903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational and Efficient Preparative Isolation of Natural Products by MPLC-UV-ELSD based on HPLC to MPLC Gradient Transfer.
    Challal S; Queiroz EF; Debrus B; Kloeti W; Guillarme D; Gupta MP; Wolfender JL
    Planta Med; 2015 Nov; 81(17):1636-43. PubMed ID: 25922910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of eluent on the ionization process in liquid chromatography-mass spectrometry.
    Kostiainen R; Kauppila TJ
    J Chromatogr A; 2009 Jan; 1216(4):685-99. PubMed ID: 18799161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving natural products identification through targeted LC-MS/MS in an untargeted secondary metabolomics workflow.
    Hoffmann T; Krug D; Hüttel S; Müller R
    Anal Chem; 2014 Nov; 86(21):10780-8. PubMed ID: 25280058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention pattern profiling of fungal metabolites on mixed-mode reversed-phase/weak anion exchange stationary phases in comparison to reversed-phase and weak anion exchange separation materials by liquid chromatography-electrospray ionisation-tandem mass spectrometry.
    Apfelthaler E; Bicker W; Lämmerhofer M; Sulyok M; Krska R; Lindner W; Schuhmacher R
    J Chromatogr A; 2008 May; 1191(1-2):171-81. PubMed ID: 18199445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
    Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
    J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent applications of liquid chromatography-mass spectrometry in natural products bioanalysis.
    Xing J; Xie C; Lou H
    J Pharm Biomed Anal; 2007 Jun; 44(2):368-78. PubMed ID: 17317073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in qualitative and quantitative analysis of phytochemical constituents and their metabolites using liquid chromatography-mass spectrometry.
    Wu H; Guo J; Chen S; Liu X; Zhou Y; Zhang X; Xu X
    J Pharm Biomed Anal; 2013 Jan; 72():267-91. PubMed ID: 23031576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear magnetic resonance and liquid chromatography-mass spectrometry combined with an incompleted separation strategy for identifying the natural products in crude extract.
    Dai D; He J; Sun R; Zhang R; Aisa HA; Abliz Z
    Anal Chim Acta; 2009 Jan; 632(2):221-8. PubMed ID: 19110097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of phase I metabolites of cardiovascular and anti-ulcer drugs in surface water samples with liquid-chromatography-mass spectrometry methods.
    Varga R; Eke Z; Torkos K
    Talanta; 2011 Sep; 85(4):1920-6. PubMed ID: 21872039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-high performance supercritical fluid chromatography coupled with quadrupole-time-of-flight mass spectrometry as a performing tool for bioactive analysis.
    Grand-Guillaume Perrenoud A; Guillarme D; Boccard J; Veuthey JL; Barron D; Moco S
    J Chromatogr A; 2016 Jun; 1450():101-11. PubMed ID: 27156735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of host-cell proteins in biotherapeutic proteins by LC/MS approaches.
    Doneanu CE; Chen W
    Methods Mol Biol; 2014; 1129():341-50. PubMed ID: 24648086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput profiling of microbial extracts.
    Ito T; Odake T; Katoh H; Yamaguchi Y; Aoki M
    J Nat Prod; 2011 May; 74(5):983-8. PubMed ID: 21495658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of rat urinary metabolites of rifabutin using LC-MSn and LC-HR-MS.
    Prasad B; Singh S
    Eur J Pharm Sci; 2010 Sep; 41(1):173-88. PubMed ID: 20558285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad-spectrum separations in metabolomics using enhanced polar LC stationary phases: a dedicated evaluation using plant metabolites.
    t'Kindt R; Alaerts G; Vander Heyden Y; Deforce D; Van Bocxlaer J
    J Sep Sci; 2007 Aug; 30(13):2002-11. PubMed ID: 17638371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive multi-residue method for the target analysis of pesticides in crops using liquid chromatography-tandem mass spectrometry.
    Hiemstra M; de Kok A
    J Chromatogr A; 2007 Jun; 1154(1-2):3-25. PubMed ID: 17442324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS.
    Halket JM; Waterman D; Przyborowska AM; Patel RK; Fraser PD; Bramley PM
    J Exp Bot; 2005 Jan; 56(410):219-43. PubMed ID: 15618298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.